National and Kapodistrian University of Athens
Μελέτη της συγκέντρωσης της s-ctx και της οστεοκαλσίνης στον ορό ασθενών με καρκίνο του προστάτη που λαμβάνουν διφωσφονικά και αξιολόγηση του κινδύνου εμφάνισης οστεονέκρωσης των γνάθων
Abstract
dc:descriptionObjective: To examine the predictive value of osteocalcin (OC) and C-terminal telopeptide (CTX) levels for jaw osteonecrosis in high-risk prostate cancer (PCa) patients taking bisphosphonates (BPs).Material and methods: Twenty-four patients were prospectively recruited in this study and followed from 2011 to 2015. All patients were diagnosed with metastatic PCa with secondary bone deposits and were on androgen deprivation therapy (ADT). All participants were started on 4mg of zoledronic acid intravenously every 4 weeks for two years. The patients were reviewed every three months with full blood count, blood biochemistry, PSA and measurement of OC and CTX. Patients also underwent dental/ oral examination. OC and CTX levels in serum were calculated using the ELISA method.Results: A significant decrease in PSA levels was found (β=-0.06, SE=0.02, p=0.006). The levels of OC (β=-0.46, SE=0.14, p=0.001) and CTX (β=-0.01, SE=0.004, p=0.007) also decreased significantly during the two years of follow up. Osteonecrosis of the jaw was identified in three patients at two years. Patients with osteonecrosis also showed a decrease in OC and CTX levels. The mean OC reduction was 77.3% for patients with osteonecrosis and 12.6% for patients without osteonecrosis. The mean CTX reduction was 44.1% for patients with osteonecrosis and 9.62% for patients without osteonecrosis.Conclusion: Our study demonstrated no clear association between the levels of serum OC and CTX and bisphosphonate-related osteonecrosis of the jaw (BRONJ). To date, there is no clinically useful biomarker for the prediction of jaw osteonecrosis. More studies are needed using different bone turnover markers in order to identify patients at risk for BRONJ.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Delaka, Andriana
- Δελακά, Ανδριάνα
Subjects
dc:subject × 14- Καρκίνος του προστάτη
- Διφωσφονικό ζολεδρονικό οξύ
- Οστεοκαλσίνη
- Αμινοτελικό τελοπεπτίδιο του κολλαγόνου Ι
- Οστεονέκρωση των γνάθων
- Prostate cancer
- Bisphosphonates
- Osteocalcin
- c-terminal telopeptide of collagen type 1
- Osteonecrosis of the jaws
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43867